Search
agalsidase beta (Fabrazyme, Replagal)
Tradename: Fabrazyme (FDA approved 2003)
Indications:
- Fabry's disease
Mechanism of action:
- recombinant human alpha-galactosidase A
Related
pegunigalsidase alfa-iwxj (Elfabrio)
General
alpha-galactosidase A (ceramide trihexosidase, melibiase, GLA)
recombinant protein; chimer
metabolic agent (metabolic modifier)
References
Prescriber's Letter 11(2):suppl 2004